Poliklinika Solmed d.o.o.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Poliklinika Solmed, researchers focus on cardiovascular health, aiming to test new therapies that reduce heart attacks, stroke, and related events.
- Acute Coronary Syndrome
- Atrial Fibrillation
- Heart failure with preserved ejection fraction
- Atherosclerotic cardiovascular disease
The site’s investigators collaborate with regional hospitals to advance treatment options for patients with heart conditions.
Digestive System Diseases
Studies in the digestive field target inflammatory bowel conditions and seek safer, effective medicines for chronic gut inflammation.
- Crohn's disease
- Moderate to severe Crohn's disease
- Ulcerative colitis
Poliklinika Solmed’s gastroenterology team engages participants in long‑term extensions to monitor safety and lasting benefits.
Immune System Diseases
The clinic investigates autoimmune disorders, evaluating novel agents that may control systemic inflammation and improve quality of life.
- Systemic Lupus Erythematosus
- Autoimmune disease
- Hidradenitis Suppurativa
- Alopecia Areata
Researchers at the Zagreb site are enrolling adults and adolescents to broaden understanding of immune‑modulating therapies.
Nervous System Diseases
Research on the nervous system examines multiple sclerosis and related neuro‑inflammatory conditions, testing treatments that could slow disease progression.
- Multiple sclerosis
- Relapsing‑remitting multiple sclerosis
The trial network includes pharmacokinetic comparisons to established biologics, supporting evidence‑based care.
Nutritional and Metabolic Diseases
Metabolic studies aim to improve management of type 2 diabetes and related metabolic risk factors through innovative drug combinations.
- Type 2 diabetes
- Glycemic control
- Metabolic syndrome
The site partners with endocrinology specialists to assess blood‑sugar outcomes and weight management.
Skin and Connective Tissue Diseases
Dermatology trials focus on severe alopecia areata and other skin disorders, exploring oral therapies that promote hair regrowth.
- Alopecia Areata
- Hidradenitis Suppurativa
- Skin inflammation
Poliklinika Solmed provides a supportive environment for both adult and adolescent participants.
Immune System Processes
Investigations into immune system processes underpin many of the site’s autoimmune and inflammatory studies, seeking to clarify mechanisms of disease activity.
- Systemic inflammation
- Cytokine signaling
- Immune modulation
Findings from these projects help guide the design of future therapeutic trials across multiple disease areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 15 therapeutic areas and 15 of 79 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 78 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 22 by active trials.
lock +21 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG10trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Poliklinika Solmed d.o.o.
lock Showing 1 of 75 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Dose-Finding Study to Evaluate the Efficacy and Safety of Once-Weekly Subcutaneous NNC0662-0419 in Participants with Type 2 Diabetes | Novo Nordisk A/S | Phase II | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 79 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 6 | Unknown | 2017-07-27 | 2024-12-03 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.